Tiziana Life Sciences Ltd TLSA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.18M | 3.18M | 4.01M | 4.01M | 7.25M |
| Total Receivables | 4.32M | 4.32M | 4.08M | 4.08M | 4.95M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.94M | 1.94M | 285.00K | 285.00K | 517.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 174.00K | 174.00K | -- |
| Total Current Assets | 9.44M | 9.44M | 8.55M | 8.55M | 12.72M |
|
|
|||||
| Total Current Assets | 9.44M | 9.44M | 8.55M | 8.55M | 12.72M |
| Net Property, Plant & Equipment | 985.00K | 985.00K | 499.00K | 499.00K | 150.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.66M | 11.66M | 11.50M | 11.50M | 16.60M |
|
|
|||||
| Total Accounts Payable | 10.48M | 10.48M | 7.17M | 7.17M | 5.48M |
| Total Accrued Expenses | 2.65M | 2.65M | 3.29M | 3.29M | 1.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 106.00K | 106.00K | 222.00K | 222.00K | 107.00K |
| Total Finance Division Other Current Liabilities | 355.00K | 355.00K | 527.00K | 527.00K | 113.00K |
| Total Other Current Liabilities | 355.00K | 355.00K | 527.00K | 527.00K | 113.00K |
| Total Current Liabilities | 13.58M | 13.58M | 11.21M | 11.21M | 7.40M |
|
|
|||||
| Total Current Liabilities | 13.58M | 13.58M | 11.21M | 11.21M | 7.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 826.00K | 826.00K | 234.00K | 234.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.41M | 14.41M | 11.44M | 11.44M | 7.40M |
|
|
|||||
| Common Stock & APIC | 43.57M | 43.57M | 34.78M | 34.78M | 31.91M |
| Retained Earnings | -175.50M | -175.50M | -163.11M | -163.11M | -150.46M |
| Treasury Stock & Other | 129.18M | 129.18M | 128.38M | 128.38M | 127.76M |
| Total Common Equity | -2.75M | -2.75M | 52.00K | 52.00K | 9.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.75M | -2.75M | 52.00K | 52.00K | 9.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.75M | -2.75M | 52.00K | 52.00K | 9.20M |
|
|
|||||